Innova Medical Technologies provides superior medical products and services that address unmet clinical needs in the management of patients with heart disease, diabetes, erectile dysfunction, obesity, macular degeneration, and evidence is mounting for the treatment of Multiple Sclerosis, Alzheimer's, and Parkinson's diseases.
The company's core technology, offered via External Counter Pulsation (ECP), is an FDA and U.S. Health & Human Services approved durable medical device delivering therapy which provides healthcare professionals with non-invasive solutions for patients suffering from cardiovascular diseases, the #1 killer of the human race.
Innova Medical Technologies plans to continue to grow the company by introducing expanded sales and marketing solutions for both insurance approved cardiac therapy and proven elective treatments above via Primary Care Providers through exclusive Distributors worldwide. Historically mainstream cardiac therapy has only been available via direct hospital and cardiology channels.
Our mission is to improve the health of all CVC sufferers, and others benefitted through out non-invasive, life-saving, FDA approved treatment options via primary care providers around the world.
Innova Med shall also continually strives to be an instrument of global change through education, patient advocacy and subsidized patient care to the indigent through our non-profit; and shall effectively serve our employees, investors, and local community by offering a sustainable, profitable and integrity driven business model and the opportunity for a greater quality of life to all stakeholders alike.